Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation;
S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act;
H.R. 5378, Lower Costs, More Transparency Act;
Issues related to Medicaid Drug Rebate Program;
Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)
Healthcare workforce shortage issues;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization;
Expiring healthcare extenders;
S. 1339, Pharmacy Benefit Manager Reform Act;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47);
Issues related to cybersecurity, artificial intelligence, and healthcare data privacy
Duration: November 1, 2007
to
present
General Issues: Medicare/Medicaid , Health Issues , Homeland Security , Telecommunications , Insurance , Budget/Appropriations , Taxation/Internal Revenue Code , Pharmacy , Trade (Domestic & Foreign) , Copyright/Patent/Trademark
Spending: about $3,855,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, White House Office, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), U.S. Senate,, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Y
Y
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Elizabeth Barnett Legislative Assistant, Sen. Blanche Lincoln
Speechwriter, Sen. Blanche Lincoln
Legislative Correspondent, Sen. Blanche Lincoln
Staff Assist., Senate Energy & Natural Re. Com.
Tracy Spicer Dep.Chief of Staff, Sen. Edward M. Kennedy
Political Director, Sen. Edward M. Kennedy
Legislative Assistant, Sen. Edward M. Kennedy
Special Assistant, Sen Edward M Kennedy
Staff Assistant, Sen. Edward M. Kennedy
Special Assistant, Sen. Edward M Kennedy
Amy Tejral Legislative Director, Senator Ben Nelson
Legislative Director, Sen. Ben Nelson
Laurie Sullivan n/a
Jordan LaCrosse n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 22.
Original Filing: 301574289.xml
Lobbying Issues
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation;
S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act;
H.R. 5378, Lower Costs, More Transparency Act;
Issues related to Medicaid Drug Rebate Program;
Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice)
Lobbying Issues
Healthcare workforce shortage issues;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization;
Expiring healthcare extenders;
S. 1339, Pharmacy Benefit Manager Reform Act;
H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42);
H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47);
Issues related to cybersecurity, artificial intelligence, and healthcare data privacy
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 22.
Original Filing: 301539402.xml
Lobbying Issues
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation;
Senate Finance Committees Better Mental Health Care, Lower Cost Drugs and Extenders Act (Discussion Draft);
S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act;
H.R. 5378, Lower Costs, More Transparency Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Healthcare workforce shortage issues;
Cybersecurity and artificial intelligence in the healthcare sector;
Issues related to data privacy in the healthcare space;
Issues related to national health information technology standards;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization;
Issues related to insulin out of pocket costs;
S. 954, Affordable Insulin Now Act of 2023;
S. 1269, INSULIN Act of 2023;
Expiring healthcare extenders;
S. 1339, Pharmacy Benefit Manager Reform Act
3rd Quarter, 2023
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2023.
Original Filing: 301511013.xml
Lobbying Issues
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation
Lobbying Issues
Healthcare workforce shortage issues;
Cybersecurity and artificial intelligence in the healthcare sector;
Issues related to data privacy in the healthcare space;
Issues related to national health information technology standards;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization;
Issues related to insulin out of pocket costs;
S. 954, Affordable Insulin Now Act of 2023;
S. 1269, INSULIN Act of 2023
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2023.
Original Filing: 301483986.xml
Lobbying Issues
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation
Lobbying Issues
Healthcare workforce shortage issues;
Cybersecurity and artificial intelligence in the healthcare sector;
Issues related to data privacy in the healthcare space;
Issues related to national health information technology standards;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization;
Issues related to insulin out of pocket costs;
S. 954, Affordable Insulin Now Act of 2023;
S. 1269, INSULIN Act of 2023
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2023.
Original Filing: 301464266.xml
Lobbying Issues
Contract Year 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F);
CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency;
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Healthcare workforce shortage issues;
Cybersecurity in the healthcare sector;
Issues related to data privacy in the healthcare space;
Issues related to national health information technology standards;
H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic;
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 20, 2023.
Original Filing: 301439665.xml
Lobbying Issues
Value of prescription drugs;
Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S. 3018/HR. 3173, Improving Seniors Timely Access to Care Act of 2021;
Cassidy/Scott RFI on dual eligible beneficiaries;
Contract Year 2024 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule CMS-4201-P
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Inflation Reduction Act of 2022 (PL 117-169) - - creating Medicare negotiation of drugs, extending enhanced premium assistance for ACA marketplace plans through 2025, creating a new inflation rebate under Medicare, limiting insulin copays to $35/month, capping Medicare Part D premium growth, expanding premium and co-pay assistance on prescription drugs for low-income individuals, and capping Medicare out of pocket costs at $2,000 per year, and preventing commercial spillover of maximum fair price into markets beyond Medicare;
H.R. 2617, Consolidated Appropriations Act, 2023 - increasing Medicare Physician Fee Schedule payments, extending all Medicare telehealth flexibilities extended in the Consolidated Appropriations Act of 2022 through December 31, 2024, and extending Acute Hospital Care at Home waivers and flexibilities through December 31, 2024;
Healthcare workforce shortage issues;
Committee Print 117-1 - Improvements to Medicare Inpatient and Outpatient Mental Health Services (H.R. 8879, Inpatient Psychiatric Facility Improvement Act; H.R. 8878, To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program);
Committee Print 117-2 - Improvements to the Medicare Program Related to Physician Services and Education (H.R. 432, Mental Health Access Improvement Act of 2021; H.R. 8910, Behavioral Health Integration Awareness Act of 2022; H.R. 8884, To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program; H.R. 8890, Physician Wellness Program Act of 2022; H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act);
Committee Print 117-3 - Requiring Coverage of Forensic Medical Exams with No Cost Sharing (H.R. 8891, No Surprises for Survivors Act of 2022);
Committee Print 117-4 - Improved Information in Provider Directories, Plan Definitions and Crisis Services for Private Insurance Plans (H.R. 8885, Better Health Care Directories Act; H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act; H.R. 8892, To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes);
Committee Print 117-5 - Improved Information for Network Coverage and Plan Documents in Private Insurance Plans (H.R. 8881, To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes; H.R. 8889, Readable Insurance Coverage Explanations Act (RICE Act));
Cybersecurity in the healthcare sector;
H.R. 8152, American Data Privacy and Protection Act;
Issues related to privacy in the healthcare space;
Issues related to national health information technology standards;
Consolidated Appropriations Act, 2022 (PL 117-103);
S. 3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Senate Finance Committee bipartisan Discussion Draft: Mental Health Workforce;
Bipartisan Safer Communities Act, PL 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation;
Issues related to the Public Health Emergency;
S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act;
Issues related to the White House Cancer Moonshot initiative;
Issues related to the FY 2023 President's Budget;
S. 4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413668.xml
Lobbying Issues
Value of prescription drugs;
Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S. 3018/HR. 3173, Improving Seniors Timely Access to Care Act of 2021;
Chips and Science Act (PL 117-167)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation;
Issues related to the Continuing Resolution, H.R. 6833;
Committee Print 117-1 - Improvements to Medicare Inpatient and Outpatient Mental Health Services (H.R. 8879, Inpatient Psychiatric Facility Improvement Act; H.R. 8878, To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program);
Committee Print 117-2 - Improvements to the Medicare Program Related to Physician Services and Education (H.R. 432, Mental Health Access Improvement Act of 2021; H.R. 8910, Behavioral Health Integration Awareness Act of 2022; H.R. 8884, To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program; H.R. 8890, Physician Wellness Program Act of 2022; H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act);
Committee Print 117-3 - Requiring Coverage of Forensic Medical Exams with No Cost Sharing (H.R. 8891, No Surprises for Survivors Act of 2022);
Committee Print 117-4 - Improved Information in Provider Directories, Plan Definitions and Crisis Services for Private Insurance Plans (H.R. 8885, Better Health Care Directories Act; H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act; H.R. 8892, To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes);
Committee Print 117-5 - Improved Information for Network Coverage and Plan Documents in Private Insurance Plans (H.R. 8881, To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes; H.R. 8889, Readable Insurance Coverage Explanations Act (RICE Act));
Health information technology & healthcare privacy issues;
H.R. 8152, American Data Privacy and Protection Act;
Issues related to privacy in the healthcare space;
Issues related to national health information technology standards;
Consolidated Appropriations Act, 2022 (PL 117-103);
S. 3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Senate Finance Committee bipartisan Discussion Draft: Mental Health Workforce;
Bipartisan Safer Communities Act, PL 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022;
Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation;
Issues related to the Public Health Emergency;
H.R. 5585, Advanced Research Projects Agency-Health (ARPA-H) Act;
S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act;
Issues related to the White House Cancer Moonshot initiative;
Issues related to the FY 2023 President's Budget;
S. 4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
Chips and Science Act (PL 117-167)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2022.
Original Filing: 301392659.xml
Lobbying Issues
Value of prescription drugs;
Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model;
Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage;
S.3018/HR.3173, Improving Seniors Timely Access to Care Act of 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Issues related to national health information technology standards;
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
H.R. 5376, Build Back Better Act;
Consolidated Appropriations Act, 2022 (PL 117-103);
S.3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services;
Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP;
Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth;
H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022
Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation;
Issues related to the Public Health Emergency;
H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act;
S.3819, Advanced Research Project Authority for Health (ARPA-H) Act;
Issues related to the White House Cancer Moonshot initiative;
Issues related to the FY 2023 Presidents Budget;
S.4293, Pharmacy Benefit Manager Transparency Act of 2022;
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act;
Monitor Conference negotiations between H.R. 4521, the America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to include sec 80303
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2022.
Original Filing: 301370980.xml
Lobbying Issues
Value of prescription drugs;
Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to vaccine hesitancy;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Issues related to national health information technology standards;
Implementation of American Rescue Plan Act of2021 (PL 117-2);
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
H.R. 5376, Build Back Better Act;
Consolidated Appropriations Act, 2022 (PL 117-103);
S.3799, PREVENT Pandemics Act;
S. 3700/H.R. 6833, Affordable Insulin Now Act;
Issues related to the Senate Finance report on mental health and mental health legislation;
Issues related to reauthorization of the FDA user fee bills;
Issues related to the Public Health Emergency;
H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act;
Issues related to the White House Cancer Moonshot initiative;
H.R. 7007, COVID Supplemental Appropriations Act, 2022;
Issues related to the FY 2023 Presidents Budget
Agencies Lobbied
U.S. Senate
Lobbying Issues
S.2875, The Cyber Incident Reporting Act of 2021
4th Quarter, 2021
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329934.xml
Lobbying Issues
Value of prescription drugs;
Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;
Senate Finance Committee Prescription Drug Reform Principles;
Extension of the Medicare Sequester;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Delay of the Rebate Rule;
PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to vaccine hesitancy;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
S. 2407, Cyber Incident Notification Act of2021 - issues related to impact on HIPAA;
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Issues related to national health information technology standards;
Implementation of American Rescue Plan Act of2021 (PL 117-2);
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs;
H.R. 5376, Build Back Better Act;
PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313572.xml
Lobbying Issues
Value of prescription drugs;
Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress;
Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress;
Senate Finance Committee Prescription Drug Reform Principles;
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021;
Proposed repeal of the CMS Rule on Most Favored Nation Model;
Delay of the Rebate Rule
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to vaccine hesitancy;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
S. 2407, Cyber Incident Notification Act of 2021 - issues related to impact on HIPAA;
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Issues related to national health information technology standards;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;
HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs;
S. 2210 Better Care Better Jobs Act;
H.R. 5376, Build Back Better Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2021.
Original Filing: 301289689.xml
Lobbying Issues
Stark Law modernization;
Value of prescription drugs;
Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress;
Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress;
Senate Finance Committee Prescription Drug Reform Principles;
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to vaccine hesitancy;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Issues related to national health information technology standards;
Implementation of American Rescue Plan Act of 2021 (PL 117-2);
Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services;
Senate HELP and Energy & Commerce Public Option RFI;
HELP Committee bipartisan efforts to improve public health and medical preparedness/response programs;
S. 2210 Better Care Better Jobs Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2021.
Original Filing: 301261733.xml
Lobbying Issues
Stark Law modernization;
Value of prescription drugs;
Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress;
Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress;
Extension of the Medicare Sequester;
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;
S. 748, Medicare Sequester Relief Act;
Telehealth Expansion Act;
Telehealth issues related to COVID-19;
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to vaccine hesitancy;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of implementation of Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (PL 116-123);
Continued monitoring of implementation of Families First Coronavirus Response Act (PL 116-127);
Continued monitoring of implementation of CARES Act (PL 116-136) - proposals related to physician and provider relief;
Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);
Issues related to national health information technology standards;
H.R. 1319,- American Rescue Plan Act of 2021 (PL 117-2)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 21, 2021.
Original Filing: 301243765.xml
Lobbying Issues
Stark Law modernization;
H.R. 3461, Community-Based Independence for Seniors Act;
Value of prescription drugs;
S. 2543, Prescription Drug Pricing Reduction Act of 2019;
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;
Extension of the Medicare Sequester
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R, 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
S. 3599 - Healthcare Workforce Resilience Act;
H.R. 925, The Heroes Act;
Issues related to national health information technology standards;
H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
3rd Quarter, 2020
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222873.xml
Lobbying Issues
Stark Law modernization;
H.R. 3461, Community-Based Independence for Seniors Act;
Value of prescription drugs;
S. 2543, Prescription Drug Pricing Reduction Act of 2019;
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R, 6800, The Heroes Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
S. 3599 - Healthcare Workforce Resilience Act;
H.R. 925, The Heroes Act;
Issues related to national health information technology standards
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
2nd Quarter, 2020
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2020.
Original Filing: 301201571.xml
Lobbying Issues
Stark Law modernization;
H.R. 3461, Community-Based Independence for Seniors Act;
Value of prescription drugs;
S. 2543, Prescription Drug Pricing Reduction Act of 2019;
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
Continued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;
Continued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;
H.R, 6800, HEROES Act (including Medicare Accelerated Payment program, increased FMAP payments, COBRA coverage, increased funding for HHS Provider Fund, changes to the Paycheck Protection Program, medical liability reform);
S. 3599 - Healthcare Workforce Resilience Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
1st Quarter, 2020
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 17, 2020.
Original Filing: 301170095.xml
Lobbying Issues
Stark Law modernization;
H.R. 3461, Community-Based Independence for Seniors Act;
Value of prescription drugs;
S. 2543, Prescription Drug Pricing Reduction Act of 2019;
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
H.R. 6074 (Public Law 116-123), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;
H.R. 6201 (Public Law 116-127), Families First Coronavirus Response Act;
H.R. 748 (Public Law 116-136), Coronavirus Aid, Relief, and Economic Security (CARES) Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 18, 2020.
Original Filing: 301120913.xml
Lobbying Issues
Stark Law modernization;
H.R. 3462, Community-Based Independence for Seniors Act;
Value of prescription drugs;
S. 2543, Prescription Drug Pricing Reduction Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space;
H.R. 1865, Consolidated Domestic and International Assistance Bill
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 17, 2019.
Original Filing: 301068899.xml
Lobbying Issues
Stark Law modernization;
Community-Based Independence for Seniors Act;
Value of prescription drugs
Lobbying Issues
Monitor healthcare cost initiatives;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
2nd Quarter, 2019
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2019.
Original Filing: 301052659.xml
Lobbying Issues
Stark Law modernization;
Community-Based Independence for Seniors Act;
Value of prescription drugs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor healthcare cost initiatives;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
Issues related to value based payment arrangements;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 19, 2019.
Original Filing: 301031112.xml
Lobbying Issues
Stark Law modernization;
Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor healthcare cost initiatives;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
Issues related to value based payment arrangements;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to privacy and data security legislation and its impact on HIPPA
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 21, 2019.
Original Filing: 301012102.xml
Lobbying Issues
Stark Law modernization;
S. 309, Community-Based Independence for Seniors Act
H.R. 4006, Community-Based Independence for Seniors Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records;
Issues related to value based payment arrangements;
Health information technology & healthcare privacy issues;
Issues related to privacy in the healthcare space
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990385.xml
Lobbying Issues
Stark Law modernization;
S. 309, Community-Based Independence for Seniors Act
H.R. 4006, Community-Based Independence for Seniors Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives;
Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2018.
Original Filing: 300970518.xml
Lobbying Issues
Stark Law modernization;
S. 309, Community-Based Independence for Seniors Act
H.R. 4006, Community-Based Independence for Seniors Act of 2017
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to opioids policies;
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act);
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);
S. 2680, Opioid Crisis Response Act of 2018;
Monitor drug pricing initiatives
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 19, 2018.
Original Filing: 300950990.xml
Lobbying Issues
Telehealth;
S. 870, CHRONIC Care Act of 2017;
Stark Law modernization;
IPAB repeal;
SNP reauthorization;
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies;
H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018;
H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936391.xml
Lobbying Issues
Telehealth;
S. 870, CHRONIC Care Act of 2017;
Stark Law modernization;
IPAB repeal;
SNP reauthorization;
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to year-end healthcare discussions/offsets for budget deal and healthcare extender policies
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905452.xml
Lobbying Issues
Telehealth;
S. 870, CHRONIC Care Act of 2017;
Stark Law modernization;
IPAB repeal;
SNP reauthorization;
S. 309, Community-Based Independence for Seniors Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, American Health Care Act of 2017;
Better Care Reconciliation Act;
Graham-Cassidy healthcare reconciliation bill
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300888642.xml
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
S. 870, CHRONIC Care Act of 2017
Stark Law modernization;
Care planning principles;
IPAB repeal;
SNP reauthorization.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, American Health Care Act of 2017;
Better Care Reconciliation Act discussion draft.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2017.
Original Filing: 300874855.xml
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
Senate Finance Committee's Chronic Care Working Group;
Stark Law modernization;
Medicate Part B Drug Payment policies;
MACRA implementation;
Care planning principles
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1628, American Health Care Act of 2017
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855990.xml
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
Senate Finance Committee's Chronic Care Working Group;
Senate HELP Committee's Innovation Working Group;
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
Opioid legislation (H.R. 953, Comprehensive Addiction and Recovery Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016);
Stark Law modernization;
CMS/CMMI Medicare Part B Drug Payment Model;
MACRA implementation;
Care planning principles;
H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act;
Zika funding;
H.R. 6, 21st Century Cures Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2016.
Original Filing: 300836834.xml
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
Senate Finance Committee's Chronic Care Working Group;
Senate HELP Committee's Innovation Working Group;
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
Opioid legislation (H.R. 953, Comprehensive Addiction and Recovery Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016);
Stark Law modernization;
CMS/CMMI Medicare Part B Drug Payment Model;
MACRA rule;
Care planning principles;
H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act;
Zika funding
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300814156.xml
Lobbying Issues
Issues related to health information cybersecurity, data security, privacy;
Patient identifier policy rider
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
Senate Finance Committee's Chronic Care Working Group;
Senate HELP Committee's Innovation Working Group;
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
Opioid legislation;
Stark Law modernization;
CMS/CMMI Medicare Part B Drug Payment Model;
MACRA rule;
Care planning principles
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2016.
Original Filing: 300799558.xml
Lobbying Issues
Issues related to health information cybersecurity, data security, privacy
Lobbying Issues
Health information technology/meaningful use/interoperability;
Telehealth;
Senate Finance Committee's Chronic Care Working Group;
Senate HELP Committee's Innovation Working Group;
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
Opiod legislation;
Stark Law modernization;
CMS/CMMI Medicare Part B Drug Payment Model;
Medicare Advantage CY2017 Call Letter and Rate Notice
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 20, 2016.
Original Filing: 300778602.xml
Lobbying Issues
Issues related to medical records and data security, privacy and cybersecurity;
meaningful use/health information technology;
issues related to transparency and interoperability
Lobbying Issues
health information technology/meaningful use/interoperability;
telehealth;
Senate Finance Committee's Chronic Care Working Group;
Senate HELP Committee's Innovation Working Group;
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
3rd Quarter, 2015
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762920.xml
Lobbying Issues
issues related to medical records and data security, privacy and cybersecurity;
meaningful use/health information technology;
issues related to transparency and interoperability
Agencies Lobbied
U.S. Senate
Lobbying Issues
health information technology/meaningful use/interoperability;
chronic care programs in Medicare;
Independent Payment Advisory Board (IPAB);
S. 704/H.R. 2704, Community Based Independence for Seniors Act;
telehealth
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 17, 2015.
Original Filing: 300737847.xml
Lobbying Issues
issues related to ACA implementation;
issues related to medical records and data security, privacy and cybersecurity;
meaningful use;
issues relating to transparency and interoperability
Agencies Lobbied
U.S. Senate
Lobbying Issues
entitlement reforms - Medicare reform proposals;
health information technology / meaningful use;
chronic care programs in Medicare;
Independent Payment Advisory Board (IPAB);
S. 704/H.R. 2704, Community Based Independence for Seniors Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2015.
Original Filing: 300724075.xml
Lobbying Issues
issues related to ACA implementation and open enrollment;
issues related to data security, privacy and cybersecurity;
meaningful use;
issues relating to transparency and interoperability;
risk corridors
Lobbying Issues
entitlement reforms - Medicare reform proposals;
health information technology / meaningful use;
chronic care programs in Medicare
4th Quarter, 2014
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 20, 2015.
Original Filing: 300707857.xml
Lobbying Issues
Issues related to ACA implementation and open enrollment;
issues related to data security and privacy;
meaningful use stage 2;
issues relating to transparency and interoperability;
ICD-10 delay;
risk corridors
Lobbying Issues
Entitlement reforms - Medicare reform proposals;
health information technology / meaningful use;
chronic care programs in Medicare
3rd Quarter, 2014
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 18, 2014.
Original Filing: 300681846.xml
Lobbying Issues
Issues related to ACA implementation and open enrollment;
issues related to data security and privacy;
meaningful use state 2;
issues relating to transparency
Lobbying Issues
Entitlement reforms - Medicare reform proposals;
health information technology / meaningful use;
issues related to noninterference, preferred pharmacy networks and restriction in number of Part D plans per sponsor contained in CMS's Part D proposed rule;
chronic care programs in Medicare
2nd Quarter, 2014
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2014.
Original Filing: 300663800.xml
Lobbying Issues
Entitlement reforms - Medicare reform proposals;
Health information technology / meaningful use;
H.R. 4302, Protecting Access to Medicare Act of 2014, issues related to Sustainable Growth Rate (SGR) reform;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, issues related to Sustainable Growth Rate (SGR) reform; Issues related to noninterference, preferred pharmacy networks and restriction in number of Part D plans per sponsor contained in CMS's Part D proposed rule;
Medicare Advantage payment rates contained in CMS 2014 Call Letter
Lobbying Issues
Issues related to ACA implementation;
Issues related to data security and privacy;
Issues relating to tranparency
1st Quarter, 2014
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 21, 2014.
Original Filing: 300646182.xml
Lobbying Issues
H.R. 2663, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings;
S. 1422, A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings;
Entitlement reforms - Medicare reform proposals;
Health information technology / meaningful use;H.R. 4302, Protecting Access to Medicare Act of 2014, issues related to Sustainable Growth Rate (SGR) reform;
S. 2110, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, issues related to Sustainable Growth Rate (SGR) reform;
Issues related to noninterference, preferred pharmacy networks and restriction in number of Part D plans per sponsor contained in CMS's Part D proposed rule;
Medicare Advantage payment rates contained in CMS 2014 Call Letter
Lobbying Issues
Issues related to ACA implementation;
Issues related to data security and privacy
Agencies Lobbied
U.S. Senate
4th Quarter, 2013
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 21, 2014.
Original Filing: 300625500.xml
Lobbying Issues
CBO scoring for preventive health savings;
H.R. 2663, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings;
S. 1422, A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings;
Entitlement reforms - Medicare reform proposals;Health information technology / meaningful use;
Sustainable Growth Rate (SGR) reform
Lobbying Issues
Telemedicine;
H.R. 3077, TELEmedicine for MEDicare Act of 2013 (TELE-MED Act of 2013)
3rd Quarter, 2013
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 21, 2013.
Original Filing: 300606688.xml
Lobbying Issues
Entitlement reforms - Medicare reform proposals;
Health information technology / meaningful use;
Sustainable Growth Rate (SGR) reform;
CBO scoring for preventive health savings;H.R. 2663, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings;
S. 1422, A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 22, 2013.
Original Filing: 300586538.xml
Lobbying Issues
Entitlement reforms - Medicare reform proposals;
Health information technology / meaningful use;
Independent Payment Advisory Board (IPAB);
Sustainable Growth Rate (SGR) reform
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 22, 2013.
Original Filing: 300564398.xml
Lobbying Issues
ACA's Physician Payment Sunshine Act rule;
workplace prevention and wellness programs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Entitlement reform - Medicare reform proposals;
Health information technology meaningful use;
Independent Payment Advisory Board (IPAB)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 22, 2013.
Original Filing: 300542652.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
age rating;
delivery system reforms;
essential benefits package;Federal rate review;
health insurance exchanges;
insurance tax;
MLR - medical loss ratio;
premium impact of ACA implementation;
SGR - sustainable growth rate
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Debt ceiling, sequestration, fiscal cliff discussions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare reform;
entitlement reforms;
Congressional Budget Office scoring rules for preventive health initiatives
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 21, 2012.
Original Filing: 300516222.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
age rating;
delivery system reforms;
essential benefits package;Federal rate review;
health insurance exchanges;
insurance tax;
MLR - medical loss ratio;
premium impact of ACA implementation;
SGR - sustainable growth rate
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Debt ceiling, sequestration, fiscal cliff discussions
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2012.
Original Filing: 300499251.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
essential benefits package;
Federal rate review;
insurance tax;health insurance exchanges;
health status rating;
individual coverage requirement;
individual market reform;
MLR - medical loss ratio;
preventive services;
SGR - sustainable growth rate;
women's preventive services;
delivery system reforms
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Independent Payment Advisory Board (IPAB);
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2012.
Original Filing: 300475470.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
essential benefits package;
Federal rate review;
health information technology/electronic health records;health insurance exchanges;
health status rating;
individual coverage requirement;
individual market reform;
medical loss ratios (benefits for individuals as well as populations; consistent reporting requirements for all insurers; quality improvement definition; transition for smaller states and plans);
preventive services;
privacy;
risk adjustment, centralized database;
women's preventive services
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Independent Payment Advisory Board (IPAB);
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 20, 2012.
Original Filing: 300452566.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
essential benefits package;
Federal rate review;
health information technology/electronic health records;health insurance exchanges;
health status rating;
individual coverage requirement;
individual market reform;
medical loss ratios (benefits for individuals as well as populations; consistent reporting requirements for all insurers; quality improvement definition; transition for smaller states and plans);
preventive services;
privacy;
risk adjustment, centralized database;
women's preventive services
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Independent Payment Advisory Board (IPAB);
Medigap;
Increasing eligibility age for Medicare from 65 to 67
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2011.
Original Filing: 300423944.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
essential benefits package;
Federal rate review;
health information technology/electronic health records;health insurance exchanges;
health status rating;
individual coverage requirement;
individual market reform;
medical loss ratios (benefits for individuals as well as populations; consistent reporting requirements for all insurers; quality improvement definition; transition for smaller states and plans);
preventive services;
privacy;
risk adjustment, centralized database;
women's preventive services
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Employee group waiver plan;
Independent Payment Advisory Board (IPAB);
Medigap;
increasing eligibility age for Medicare from 65 to 67
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 19, 2011.
Original Filing: 300398819.xml
Lobbying Issues
Implementation of healthcare and insurance market reform, including issues related to:
claims and appeals;
disclosure requirements;
essential benefits package;Federal rate review;
health insurance exchanges;
health status rating;
high risk pool program;
individual coverage requirement;
individual market reform;
medical loss ratios (benefits for individuals as well as populations; consistent reporting requirements for all insurers; quality improvement definition; transition for smaller states and plans);
part-time worker provisions;
premium assistance;
preventive services;
privacy;
rescissions;
small group market reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Employee group waiver plan;
Independent Payment Advisory Board (IPAB);
Issues relating to debt ceiling
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 20, 2011.
Original Filing: 300380175.xml
Lobbying Issues
Issues related to HIPAA privacy;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, exchanges;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal rate review legislation;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, and exchanges
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4, Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011, issues relating to offset of repeal of 1099 reporting
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 19, 2011.
Original Filing: 300343766.xml
Lobbying Issues
HR 4994, Medicare and Medicaid Extenders Act of 2010 - physician fix/sustainable growth rate (SGR)
S. 3742, Data Security and Breach Notification Act of 2010 regarding HIPAA carve-out;
S.1490, Personal Data Privacy and Security Act - privacy, identity theft;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, exchanges
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 3742, Data Security and Breach Notification Act of 2010 regarding HIPAA carve-out;
S. 3078 Health Insurance Rate Authority Act - federal rate review process;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, exchanges
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage funding;
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2010.
Original Filing: 300329123.xml
Lobbying Issues
HR 4213, Tax Extenders Act premium assistance for unemployed;
S. 3742, Data Security and Breach Notification Act of 2010 regarding HIPAA carve-out;
S.1490, Personal Data Privacy and Security Act - privacy, identity theft;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, exchanges, star quality and frailty adjuster
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 3742, Data Security and Breach Notification Act of 2010 regarding HIPAA carve-out;
S. 3078 Health Insurance Rate Authority Act - federal rate review process;
Implementation of healthcare reform, including issues related to medical loss ratio, preventive services, rate review, claims and appeals, exchanges, star quality and frailty adjuster
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 4213, Tax Extenders Act Medicare physician payment, Medicaid FMAP, Medicaid and CHIP technical corrections.
Medicare Advantage funding;
Star quality;
Frailty adjuster
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 20, 2010.
Original Filing: 300303190.xml
Lobbying Issues
HR 3590 / PL 111-148/152, Patient Protection and Affordable Care Act coverage expansions, quality improvements, delivery system reforms, cost containment, health information technology, comparative effectiveness research, administration simplification, health disparities, prevention, wellness, public health and workforce issues, fraud and abuse;
HR 4213, Tax Extenders Act premium assistance for unemployed; HR 4691, Temporary Extension Act - premium assistance for unemployed;
S.Con.Res.60, FY2011 Budget Resolution reserve funds for health priorities;
S.1490, Personal Data Privacy and Security Act - privacy, identity theft ;
HR 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3590 / PL 111-148/152, Patient Protection and Affordable Care Act health insurance cooperatives, multi-state plans, insurance market reforms, health insurance exchanges, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance, federal rate review process, restrictions on recissions, health care choice compacts, appeals procedures, disclosure requirements, high risk pool program; HR 4872, Health Care Education Reconciliation Act changes to individual coverage requirement, grandfathered plans, immediate insurance reforms, premium assistance, CLASS Act, coverage issues, quality improvements, delivery system reforms;
McCarran-Ferguson (S. 1681, HR 1583, HR 3596, S. 3217);
S. 3078 Health Insurance Rate Authority Act - federal rate review process
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3590 / PL 111-148/152 , Patient Protection and Affordable Care Act Medicare Advantage, Part D, special needs plans, Medicare cost plans, Medicaid issues including eligibility expansion and prescription drug pricing, Medicare FFS payment reform; HR 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 Medicare physician payment; HR 4213, Tax Extenders Act Medicare physician payment, Medicaid FMAP, Medicaid and CHIP technical corrections; HR 4691, Temporary Extension Act Medicare physician payment;
HR 4872, Healthcare and Education Reconciliation Act changes to Medicare Advantage funding, Medicare Part D coverage gap, Medicaid funding;
Medicare Advantage funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3590 / PL 111-148/152, Patient Protection and Affordable Care Act premium tax, high value health plan tax, tax credits;
HR 4872, Health Care and Education Reconciliation Act changes to premium tax, high-value health plan tax; annual insurer assessment, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurers executive compensation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 19, 2010.
Original Filing: 300266855.xml
Lobbying Issues
HR 3200, America's Affordable Health Choices Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;HR 3590, Patient Protection and Affordable Care Act - coverage expansions, quality improvements, delivery system reforms, cost containment, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
HR 3962, Affordable Health Care for America Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
HR 4213, Tax Extenders Act - COBRA assistance;
HR 4691, Temporary Extension Act - COBRA assistance;
HR 4851, Continuing Extension Act - COBRA assistance, electronic health records;
S 139, Data Breach Notification Act - data security;
S 1213, Patient-Centered Outcomes Research Act - comparative effectiveness research;
S 1490, Personal Data Privacy and Security Act - privacy, identity theft;
S 1679, Affordable Health Choices Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse;
S 1796, American's Healthy Future Act - coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 1721, CLASS Act - national LTC program;
HR 2360, SHOP Act - small employer health options;
HR 3200, America's Affordable Health Choices Act - government run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance;
HR 3590, Patient Protection and Affordable Care Act - government run health plan, health insurance cooperatives, multi-state plans, insurance market reforms, health insurance exchanges, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance, federal rate review process, health care choice compacts, appeals procedures, disclosure requirements, high risk pool program, McCarran-Ferguson Act;
HR 3962, Affordable Health Care for America Act - government run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance, federal rate review process, health care choice compacts, high risk pool program, McCarran Ferguson Act;
HR 4757, Health Insurance Rate Authority Act - federal rate review process;
HR 4872, Health Care and Education Reconciliation Act - changes to individual coverage requirement, grandfathered plans, immediate insurance reforms, premium assistance, CLASS Act, coverage issues, quality improvements, delivery system reforms;
S 391, Healthy Americans Act - comprehensive health reform;
S 697, CLASS Act - national LTC program;
S 979, SHOP Act - small employer health options;
S 1177, Confidence in Long-Term Care Insurance Act - LTC consumer protections;
S 1679, Affordable Health Choices Act - government run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance;
S 1681, Health Insurance Industry Antitrust Enforcement Act - changes to McCarran Ferguson Act;
S 1796, America's Health Future Act - government run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform;
S 3078, Health Insurance Rate Authority Act - federal rate review process
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3200, America's Affordable Health Choices Act - Medicare Advantage, Part D, special needs plans, Medicare cost plans, Medicaid issues including MCO provider taxes and eligibility expansion, Medigap open enrollment, Medicare FFS payment reform; HR 3590, Patient Protection and Affordable Care Act - Medicare Advantage, Part D, special needs plans, Medicare cost plans, Medicaid issues including eligibility expansion and prescription drug pricing, Medigap changes, Medicare FFS payment reform;
HR 3961, Medicare Physician Payment Reform Act - Medicare physician payment;
HR 3962, Affordable Health Care for America Act - Medicare Advantage, Part D, special needs plans , Medicare cost plans, Medicaid issues including MCO provider taxes, eligibility expansion and prescription drug pricing, Medigap changes, Medicare FFS payment reform;
HR 4213, Tax Extenders Act - Medicare Advantage, special needs plans, cost plans, Medicare physician payment, Medicaid FMAP;
HR 4691, Temporary Extension Act - Medicare physician payment;
HR 4851, Continuing Extension Act - Medicare physician payment;
HR 4872, Health Care and Education Reconciliation Act - changes to Medicare Advantage funding, Medicare Part D coverage gap, Medicaid funding;
HR Res 45 - Medicare physician payment, pay-as-you-go rules;
S 960, Medicare Early Access Act - Medicare buy-in option;
S 1307, Medicare Specialty Care Improvement and Protection Act - Medicare Advantage special needs plans;
S 1380, MedPAC Reform Act - implementation of Medicare payment policies;
S 1796, America's Healthy Future Act - Medicare Advantage, Part D, special needs plans, Medicaid issues including eligibility expansion and prescription drug rebates, Medigap restrictions, Medicare FFS payment reform;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies;
HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics;
HR 3200, America's Affordable Health Choices Act - generic biologics;
HR 3590, Patient Protection and Affordable Care Act - generic biologics;
HR 3962, Affordable Health Care for America Act - generic biologics;
S 369, Preserve Access to Affordable Generics Act - generic drugs;
S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics;
S 1679, Affordable Health Choices Act - generic biologics
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 3590, Patient Protection and Affordable Care Act - premium tax, high-value health plan tax, LTC insurance in cafeteria plans, FSA limits, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses;
HR 3962, Affordable Health Care for America Act - FSA limits, health savings accounts, eligibility of OTC drugs as tax-free expense;
HR 4872, Health Care and Education Reconciliation Act - changes to premium tax, high-value health plan tax;
S 1679, Affordable Health Choices Act - LTC insurance in cafeteria plans;
S 1796, America's Healthy Future Act - high cost health plan tax, industry tax, LTC insurance in cafeteria plans, FSA limits, employer tax exclusion, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Jan. 20, 2010.
Original Filing: 300247803.xml
Lobbying Issues
S. 1796 Americas Healthy Future Act (Baucus) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; H.R. 3590 The Patient Protection and Affordable Care Act (Reid managers amendment).H.R. 3962, Americas Affordable Health Choices Act (Dingell) coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; S. 1213, Patient-Centered Outcomes Research Act (Baucus) comparative effectiveness research; S. 1278, Consumers Health Care Act (Rockefeller) government run health plan; S. 1679, Affordable Health Choices Act (Harkin) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 1796 Americas Healthy Future Act (Baucus) Medicare Advantage, Part D, special needs plans, Medicaid issues including eligibility expansion and prescription drug rebates, Medigap restrictions, Medicare FFS payment reform; H.R. 3590 The Patient Protection and Affordable Care Act (Reid managers amendment). H.R. 3962, Americas Affordable Health Choices Act (Dingell) Medicare Advantage, Part D, special needs plans, Medicaid issues including MCO provider taxes and eligibility expansion, Medigap open enrollment, Medicare FFS payment reform; S. 1380, MedPAC Reform Act (Rockefeller) implementation of Medicare payment policies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 1796 Americas Healthy Future Act (Baucus) high-cost health plan tax, industry tax, LTC insurance in cafeteria plans, FSA limits, employer tax exclusion, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses; S. 1679, Affordable Health Choices Act (Harkin) LTC insurance in cafeteria plans; H.R. 3590 The Patient Protection and Affordable Care Act (Reid managers amendment).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
S. 1796 Americas Healthy Future Act (Baucus) government-run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform; H.R. 2360, SHOP Act (Kind) small employer health options; H.R. 3590 The Patient Protection and Affordable Care Act (Reid managers amendment). H.R. 3962, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance; S. 391, Healthy Americans Act (Wyden) comprehensive health reform; S. 697, CLASS Act (Kennedy) national LTC program; S. 979, SHOP Act (Durbin) small employer health options; S. 1679, Affordable Health Choices Act (Harkin) government-run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) generic biologics; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics; S. 1679, Affordable Health Choices Act (Harkin) generic biologics; H.R. 3590 The Patient Protection and Affordable Care Act (Reid managers amendment).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on Oct. 20, 2009.
Original Filing: 300215414.xml
Lobbying Issues
Americas Healthy Future Act (Baucus) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; H.R. 3200, Americas Affordable Health Choices Act (Dingell) coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; S. 1213, Patient-Centered Outcomes Research Act (Baucus) comparative effectiveness research; S. 1278, Consumers Health Care Act (Rockefeller) government run health plan; S. 1490, Personal Data Privacy and Security Act (Leahy) privacy, identity theft; S. 1679, Affordable Health Choices Act (Harkin) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Americas Healthy Future Act (Baucus) Medicare Advantage, Part D, special needs plans, Medicaid issues including eligibility expansion and prescription drug rebates, Medigap restrictions, Medicare FFS payment reform; H.R. 3200, Americas Affordable Health Choices Act (Dingell) Medicare Advantage, Part D, special needs plans, Medicaid issues including MCO provider taxes and eligibility expansion, Medigap open enrollment, Medicare FFS payment reform; S. 1380, MedPAC Reform Act (Rockefeller) implementation of Medicare payment policies;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Americas Healthy Future Act (Baucus) high-cost health plan tax, industry tax, LTC insurance in cafeteria plans, FSA limits, employer tax exclusion, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses; S. 1679, Affordable Health Choices Act (Harkin) LTC insurance in cafeteria plans;
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Americas Healthy Future Act (Baucus) government-run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform; H.R. 2360, SHOP Act (Kind) small employer health options; H.R. 3200, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance; S. 391, Healthy Americans Act (Wyden) comprehensive health reform; S. 697, CLASS Act (Kennedy) national LTC program; S. 979, SHOP Act (Durbin) small employer health options; S. 1679, Affordable Health Choices Act (Harkin) government-run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance;
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) generic biologics; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics; S. 1679, Affordable Health Choices Act (Harkin) generic biologics;
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on July 16, 2009.
Original Filing: 300180892.xml
Lobbying Issues
Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; Senate Finance Committee Draft Policy Options (Baucus-Grassley) coverage expansions, quality improvements, delivery system reforms, health information technology, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; House Tri-Committee Discussion Draft for Health Reform (Waxman, Rangel, Miller) coverage expansions, quality improvements, delivery system reforms, comparative effectiveness research, administrative simplification, health disparities, prevention and wellness, public health and workforce issues, fraud and abuse; H.Con.Res. 85 Budget Resolution (Spratt) health-related provisions; S.Con.Res. 13 Budget Resolution (Conrad) health-related provisions; S. 1213, Patient-Centered Outcomes Research Act (Baucus) comparative effectiveness research; S. 1278, Consumers Health Care Act (Rockefeller) government run health plan.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Senate Finance Committee Draft Policy Options (Baucus-Grassley) - Medicare Advantage funding, special needs plans, Medicaid eligibility expansion, Medicare FFS payment reform, Medicaid prescription drug rebates; House Tri-Committee Discussion Draft for Health Reform (Waxman, Rangel, Miller) - Medicare Advantage funding, special needs plans, Medicaid eligibility expansion, Medigap open enrollment; S.Con.Res. 13 Budget Resolution (Conrad) Medicare Advantage funding; H.Con.Res. 85 Budget Resolution (Spratt) health-related provisions; H.R. 2758, Medicare Specialty Care Improvement and Protection Act (Kind) Medicare Advantage special needs plans; S. 1307, Medicare Specialty Care Improvement and Protection Act (Feingold) Medicare Advantage special needs plans; S. 1380, MedPAC Reform Act (Rockefeller) implementation of Medicare payment policies.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) LTC insurance in cafeteria plans; Senate Finance Committee Draft Policy Options (Baucus-Grassley) employer tax exclusion, tax exclusion for FSAs and HRAs, health savings accounts, tax deduction for itemized medical expenses.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) government-run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance; Senate Finance Committee Draft Policy Options (Baucus-Grassley) government-run health plan, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance; House Tri-Committee Discussion Draft for Health Reform (Waxman, Rangel, Miller) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, medical loss ratios, premium assistance; H.R. 1721, CLASS Act (Pallone) national LTC program; H.R. 2360, SHOP Act (Kind) small employer health options; S. 79, Healthy Businesses, Healthy Workers Reinsurance Act (Kerry) reinsurance; S. 93, Small Business Empowerment Act (Brown) small employer health options
S. 391, Healthy Americans Act (Wyden) comprehensive health reform; S. 697, CLASS Act (Kennedy) national LTC program
S. 979, SHOP Act (Durbin) small employer health options; S. 1050, Informed Consumer Choices in Health Care Act (Rockefeller) federal standards for health insurance, consumer information; S. 1177, Confidence in Long-Term Care Insurance Act (Kohl) LTC consumer protections.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $60,000. The report was filed on April 17, 2009.
Original Filing: 300152569.xml
Lobbying Issues
Healthcare Reform (Medicare Advantage, delivery system, payment system, insurance market reforms, coverage issues, access issues, quality initiatives, costs, prevention, wellness programs); HR 5918/S2895 Small business health reform; Children's Health Insurance Reauthorization Act; HR 1/S336 American Recovery and Reinvestment Act (health information technology, privacy, comparative effectiveness research, SCHIP, TAA tax credit, Medicaid buy-in, FMAP.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CMS Advance Notice of Methodological Changes for CY2010; HR 1/S336 American Recovery and Reinvestment Act (health information technology, privacy, comparative effectiveness research, SCHIP, TAA tax credit, Medicaid buy-in, FMAP.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 1/S336 American Recovery and Reinvestment Act (health information technology, privacy, comparative effectiveness research, SCHIP, TAA tax credit, Medicaid buy-in, FMAP.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
H Con Res 85/S Con Res 13 Budget Resolution (healthcare reserve fund, reconciliation).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, Avenue Solutions lobbied for Healthcare Leadership Council , earning $50,000. The report was filed on Jan. 16, 2009.
Original Filing: 300123317.xml
Lobbying Issues
HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS).S. 3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; H.R. 5613 Protecting the Medicaid Safety Net Act of 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2795/HR 5918 Small Business Health Options Program Act of 2008 (SHOP); Small Business Health Insurance reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 334 Healthy Americans Act; Universal Health Reform; S.1693 Wired for Health Care Quality Act; HR 3800 Promoting Health Information Technology Act; HR 5442 Technologies for Restoring Users Security and Trust in Health Information Act of 2008; Health Information Technology (HIT); comprehensive (or universal) health reform; HR 6444 Healthy Americans Act;S.400 and HR 2851 - Michelle's Law; HR 6357 PRO(TECH)T Act of 2008: Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008; HR 6898, Health-e Information Technology Act of 2008; Healthcare issues related to economic recovery/stimulus package (HR 1424 Emergency Economic Stabilization Act of 2008) including Children's Health Insurance Program (CHIP), Federal Medicaid Assistance Percentages (FMAP), HIT, privacy, Comparative Effectiveness Research (CER).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR. 3801/S. 1848 TAA Health Coverage Improvement Act of 2007; TAA tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2008
In Q3, Avenue Solutions lobbied for Healthcare Leadership Council , earning $50,000. The report was filed on Oct. 15, 2008.
Original Filing: 300093204.xml
Lobbying Issues
HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007.S. 3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; H.R. 5613 Protecting the Medicaid Safety Net Act of 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2795/HR 5918 Small Business Health Options Program Act of 2008 (SHOP); Small Business Health Insurance reform; S. 558 Mental Health Parity Act of 2007; HR 1424 Paul Wellstone Mental Health & Addiction Equity Act of 2007; Mental Health Parity; S. 358/HR 493 Genetic Nondiscrimination Act of 2007; GINA.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 334 Healthy Americans Act; Universal Health Reform; S.1693 Wired for Health Care Quality Act; HR 3800 Promoting Health Information Technology Act; HR 5442 Technologies for Restoring Users Security and Trust in Health Information Act of 2008; Health Information Technology (HIT); comprehensive (or universal) health reform; HR 6444 Healthy Americans Act;S.400 and HR 2851 - Michelle's Law; HR 6357 PRO(TECH)T Act of 2008: Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008; HR 6898, Health-e Information Technology Act of 2008; HR 1424 EMERGENCY ECONOMIC STABILIZATION ACT OF 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR. 3801/S. 1848 TAA Health Coverage Improvement Act of 2007; TAA tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2008
In Q2, Avenue Solutions lobbied for Healthcare Leadership Council , earning $50,000. The report was filed on July 16, 2008.
Original Filing: 300067356.xml
Lobbying Issues
HR 6331/S.3101 Medicare Improvements for Patients and Providers Act of 2008; Medicare Advantage; Comparative Effectiveness; ESRD; E-Prescribing; HR 4296/S 2408 Medicare Electronic Medication and Safety Protection Act of 2007 (E-MEDS); S. 691/HR 1193 Kidney Care Quality & Education Act of 2007.S. 3144/HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008; Delay in competitive bidding for DME and supplies; H.R. 5613 Protecting the Medicaid Safety Net Act of 2008.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 2795/HR 5918 Small Business Health Options Program Act of 2008 (SHOP); Small Business Health Insurance reform; S. 558 Mental Health Parity Act of 2007; HR 1424 Paul Wellstone Mental Health & Addiction Equity Act of 2007; Mental Health Parity; S. 358/HR 493 Genetic Nondiscrimination Act of 2007; GINA.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 334 Healthy Americans Act; Universal Health Reform; S.1693 Wired for Health Care Quality Act; HR 3800 Promoting Health Information Technology Act; HR 5442 Technologies for Restoring Users Security and Trust in Health Information Act of 2008; Health Information Technology (HIT); comprehensive (or universal) health reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR. 3801/S. 1848 TAA Health Coverage Improvement Act of 2007; TAA tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2008
In Q1, Avenue Solutions lobbied for Healthcare Leadership Council , earning $45,000. The report was filed on April 18, 2008.
Original Filing: 300044801.xml
Lobbying Issues
S. 1783: Ten Steps to Transform Health Care in America Act
H.R. 853: Wellness and Prevention Act of 2007
H.R. 2147: Healthy Kids Act of 2007
S. 1364: Healthy Kids Act of 2007S. 334: Healthy Americans Act
H.R. 5348: American Health Benefits Program Act of 2008 (AHBP Act) H.R. 1328: The Indian Health Care Improvement Act
H.R. 5544: The Patients and Public Health Partnership Act of 2008
H.R. 5545: Ensuring the Future Physician Workforce Act of 2008
S. 2729: Ensuring the Future Physician Workforce Act of 2008
S. 2708: Caring for an Aging America Act of 2008
H.R. 5496: Public Health Preparedness Workforce Development Act of 2008
H.R. 2991: Independent Health Record Trust Act
H.R. 5442: TRUST in Health Information Act
S. 1693: Wired for Health Care Quality Act
S. 1814: Health Information Privacy and Security Act
S. 2672: A bill to provide incentives to physicians to practice in rural and medically underserved communities
H.R. 5174: Nursing and Allied Health Education Preservation Act of 2008
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 2785: Save Medicare Act of 2008
H.R. 4296/S. 2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act
H.R. 5613: Protecting the Medicaid Safety Net Act of 2008; Comparative Effectiveness; Medicare Reform
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 493: Genetic Information Nondiscrimination Act
S. 558 Mental Health Parity Act
H.R. 1424 Paul Wellstone Mental Health and Addiction Equity Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3920 Trade & Globalization Act of 2007
S 1848 Trade & Globalization Adjustment Assistance Act of 2007
S 122 Trade Adjustment Assistance Improvement Act
HR 3943 The Trade Adjustment Assistance and Training Improvements Act of 2007
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
S 1145/HR 1908 Patent Reform Act of 2007
Agencies Lobbied
U.S. Senate
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H. Con. Res. 312: Budget resolution FY2009
S. Con. Res. 70: Budget resolution FY2009
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 5719 Taxpayer Assistance & Simplification Act of 2008.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
0th Quarter, 2007
In MM, Avenue Solutions lobbied for Healthcare Leadership Council , earning $90,000. The report was filed on Aug. 3, 2007.
Original Filing: 200045069.xml
Lobbying Issues
S. 334 Healthy Americans Act
S. 1019 Universal Healthcare Choice and Access Act
H.R. 1535 Childrens Health First Act
S. 895 Childrens Health First Act
S. 628 Critical Access to Health Information Technology Act of 2007
S. 1408 Health Information Technology Act of 2007
S. 1577 Patient Safety and Abuse Prevention Act of 2007
S. 1693 Wired for Health Care Quality Act
H.R. 2723 Childrens Health Care Quality Act
S. 1226 Childrens Health Care Quality Act
S. 1364 Healthy Kids Act of 2007
S. 1082 Prescription Drug User Fee Amendments of 2007
H.R. 1368 Personalized Health Information Act of 2007
S. 1714 Small Business Childrens Health Education Act of 2007
H.R. 2132 Small Business Health Plans Act of 2007
S. 158 Access to Affordable Health Care Act
H.R. 2147 Health Kids Act of 2007
S. 401 Keep Children Covered Act of 2007
S. 1753 Health Workforce Act of 2007
S. 1455 National Health Information Technology and Privacy Advancement Act of 2007
Lobbying Issues
H.R. 2058 Helping Fill the Medicare Rx Gap Act of 2007
S. 1103 Helping Fill the Medicare Rx Gap Act of 2007
S. 1218 Medicare for All Act
H.R. 2034 Medicare for All Act
H.R. 2065 Medicare Drug Savings through Choice Act of 2007
S. 137 Preserving Medicare for All Act of 2007
H.R. 205 Medicare Prescription Drug Enrollment Extension Act of 2007
S. 3 Medicare Prescription Drug Price Negotiation Act of 2007
H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007
H.R. 1218 Medicare Prescription Drug and Improvement Act of 2007
H.R. 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D
H.R. 118 To amend part D title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries
H.R. 2056 Medicare Part D Improvement Act of 2007
S. 1507 Access to Medicare Data Act of 2007
H.R. 1536 Prescription Coverage Now Act of 2007
S. 28 Generics First Act of 2007
H.R. 932 To amend part D of title XVIII of the Social Security Act to limit the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals
H.R. 2945 Medicare Advantage Truth in Advertising Act of 2007
S. 273 Prescription Drug and Health Improvement Act of 2007
S. 1102 Part D Equity for Low Income Seniors Act of 2007
S. 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007
Lobbying Issues
H.R. 15 National Health Insurance Act
S. 1224 Childrens Health Insurance Program (CHIP) Reauthorization Act of 2007
H.R. 676 United States National Health Insurance Act
S. 1690 Small Business Health Insurance Options Act of 2007
H.R. 493 Genetic Information Nondiscrimination Act of 2007
S. 358 Genetic Information Nondiscrimination Act of 2007
H.R. 1329 Guaranteed Access for SCHIPs Target Population Act of 2007
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...